Intranasal vaccine for use against disease caused by...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/245 (2006.01) A61K 9/72 (2006.01) A61K 39/108 (2006.01) A61P 1/12 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2629088

The invention relates to an intranasal peptide vaccine for use against infection caused by enterotoxigenic Escherichia coli (ETEC), containing a common linear protein epitope known as CLE which is recognised by serums of patients infected with the bacteria and which is associated with a mucosal adjuvant comprising cholera toxin subunit B, known as CTB. The invention relates to a peptide containing twenty amino acids, which is located in the linear sequence of the CFA/I fimbria of enterotoxigenic Escherichia coli.

La présente invention concerne un vaccin peptidique intranasal contre une infection causée par l'ETEC, contenant un épitope protéique linéaire commun désigné sous le nom de CLE, reconnu par le sérum de patients infectés par la bactérie, et associé à un adjuvant des muqueuses qui constitue la sous-unité B de la toxine du coléra désignée sous le nom de CTB. Il s'agit d'un peptide de vingt acides aminés localisés dans la séquence linéaire du fimbria CFA/I de l'Escherichia coli entérotoxigénique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intranasal vaccine for use against disease caused by... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intranasal vaccine for use against disease caused by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intranasal vaccine for use against disease caused by... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1473790

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.